Tg Therapeutics (TGTX) Tax Provisions (2012 - 2026)

Tg Therapeutics' Tax Provisions history runs 5 years deep, the most recent figure standing at $600000.0 for Q1 2026.

• On a quarterly basis, Tax Provisions rose 50.0% year-over-year to $600000.0 in Q1 2026; TTM through Mar 2026 was -$339.6 million, a 7349.92% decrease from a year earlier, with the FY2025 full-year figure at -$339.8 million, down 6736.8% from the prior year.
• Tax Provisions slipped to $600000.0 in Q1 2026 per TGTX's latest filing, from $22.0 million in the prior quarter.
• Across five years, Tax Provisions topped out at $22.0 million in Q4 2025 and bottomed at -$365.0 million in Q3 2025.
• The 4-year median for Tax Provisions is $214500.0 (2024), against an average of -$34.5 million.
• Biggest YoY gain for Tax Provisions was 1279.31% in 2025; the steepest drop was 91346.5% in 2025.
• Year by year, Tax Provisions stood at -$700000.0 in 2023, then tumbled by 622.71% to -$5.1 million in 2024, then jumped by 535.09% to $22.0 million in 2025, then sank by 97.27% to $600000.0 in 2026.
• Per Business Quant, the three latest TGTX Tax Provisions figures stand at $600000.0 (Q1 2026), $22.0 million (Q4 2025), and -$365.0 million (Q3 2025).